Compare CCO & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCO | AORT |
|---|---|---|
| Founded | 1995 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Advertising | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2005 | 1996 |
| Metric | CCO | AORT |
|---|---|---|
| Price | $2.41 | $20.36 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | $2.12 | ★ $49.40 |
| AVG Volume (30 Days) | ★ 4.7M | 728.7K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 110.81 | ★ 165.62 |
| EPS | N/A | ★ 0.03 |
| Revenue | ★ $1,604,140,000.00 | $298,836,000.00 |
| Revenue This Year | $5.35 | $14.20 |
| Revenue Next Year | $4.26 | $11.20 |
| P/E Ratio | ★ N/A | $670.67 |
| Revenue Growth | 6.57 | ★ 18.01 |
| 52 Week Low | $1.00 | $19.16 |
| 52 Week High | $2.43 | $48.25 |
| Indicator | CCO | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 59.52 | 25.08 |
| Support Level | $2.37 | $19.16 |
| Resistance Level | $2.41 | $24.70 |
| Average True Range (ATR) | 0.01 | 1.06 |
| MACD | 0.00 | 0.20 |
| Stochastic Oscillator | 100.00 | 9.43 |
Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.